Study #2020-1280
Phase II Trial of Olaparib in Combination with Ceralasertib in Patients with Recurrent Osteosarcoma
MD Anderson Study Status
Enrolling
Treatment Agent
Olaparib, Ceralasertib
Description
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of the study drugs involved in this study are: * Olaparib * Ceralasertib
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Osteosarcoma, Osteosarcoma Recurrent
Study phase:
Phase II
Physician name:
John Livingston
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.